Title

Urinary Biomarkers Of Bladder Cancer: An Update And Future Perspectives

Keywords

biomarker; bladder cancer; genomics; metabolomics; proteomics; urinary cytology; urine

Abstract

Bladder cancer is one of the most prevalent cancers worldwide. Early detection of bladder tumors is critical for improved patient outcomes. The standard method for detection and surveillance of bladder tumors is cystoscopy with urinary cytology. Limitations of cystoscopy and urinary cytology have brought to light the need for more robust diagnostic assays. Ideally, such assays would be applicable to noninvasively obtained, voided urine, and be designed not only for diagnosis, but also for monitoring disease recurrence and response to therapy. Consequently, the development of a noninvasive urine-based assay would be of tremendous benefit to both patients and healthcare systems. This article reports some of the more prominent urine-based biomarkers reported in the literature. In addition, some new technologies that have been used to identify novel urinary biomarkers are highlighted. © 2013 Future Medicine Ltd.

Publication Date

10-1-2013

Publication Title

Biomarkers in Medicine

Volume

7

Issue

5

Number of Pages

779-790

Document Type

Review

Personal Identifier

scopus

DOI Link

https://doi.org/10.2217/bmm.13.73

Socpus ID

84884572052 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/84884572052

This document is currently not available here.

Share

COinS